Lenalidomide in Combination With R-CHOP Produces High Response Rates and Progression-Free Survival in New, Untreated Diffuse Large B Cell Lymphoma Transformed From Follicular Lymphoma: Results From the Phase 2 MC078E Study
Social Science Research Network